World Journal of Endocrine Surgery

Register      Login

VOLUME 14 , ISSUE 3 ( September-December, 2022 ) > List of Articles

Original Article

Endocrine-related Abnormalities in Locally Advanced Head and Neck Cancer Surgery Patients after Chemoradiation: A Myth or Mystery

Keywords : Chemoradiation, Endocrine abnormalities, Head and neck cancer, Hypocalcemia, Hyponatremia, Hypothyroidism, Neck surgery

Citation Information : Endocrine-related Abnormalities in Locally Advanced Head and Neck Cancer Surgery Patients after Chemoradiation: A Myth or Mystery. World J Endoc Surg 2022; 14 (3):69-72.

DOI: 10.5005/jp-journals-10002-1432

License: CC BY-NC 4.0

Published Online: 29-05-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Patients with head and neck malignancy with locally advanced disease often require chemoradiation, and those patients who undergo chemoradiation encounter more endocrine/metabolic-related complications after surgery. Materials and methods: We evaluated 36 locally advanced head and neck cancer patients who had undergone chemoradiation, followed by surgery during the period from February 2021 to June 2022 for various endocrine-related abnormalities, such as hyponatremia, hypokalemia, hypothyroidism, hypocalcemia, and complications associated with surgery in relation to these endocrine abnormalities. Results: Among these 36 patients, 20 patients developed hyponatremia, four patients developed hypokalemia, and nine patients developed hypocalcemia at some point of time after the surgery, and their preoperative (pre-OP) values were normal. A total of 13 patients had subclinical hypothyroidism even before the surgery. Wound morbidity was more among these patients. Conclusion: If all patients with head and neck cancers who are all undergoing surgery after chemoradiation are evaluated for electrolyte abnormalities, such as hyponatremia, hypocalcemia, and hypothyroidism, it may reduce the perioperative and postoperative (post-OP) complications and it may shorten the hospital stay, help in early recovery, and may avoid life-threatening conditions.

  1. Hashim D, Sartori S, La Vecchia C, et al. Hormone factors play a favorable role in female head and neck cancer risk. Cancer Med 2017;6(8):1998–2007. DOI: 10.1002/cam4.1136
  2. Clinicopathological profile of cancers in india: A report of hospital based Cancer registries 2021, National Cancer registry program, ICMR, section ll - chapter one, cancers of head and neck page 49.
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7–34. DOI: 10.3322/caac.21551
  4. Wang S, Liu Y, Feng Y, et al. A review on curability of cancers: more efforts for novel therapeutic options are needed. Cancers 2019;11(11):1782. DOI: 10.3390/cancers11111782
  5. Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014;170(3):G1–G47. DOI: 10.1530/EJE-13-1020
  6. Onitilo AA, Kio E, Doi SA. Tumor-related hyponatremia. Clin Med Res 2007;5(4):228–237. DOI: 10.3121/cmr.2007.762
  7. Refardt J, Kling B, Krausert K, et al. Impact of chronic hyponatremia on neurocognitive and neuromuscular function. Eur J Clin Invest 2018;48(11):e13022. DOI: 10.1111/eci.13022
  8. U.S. Food and Drug Administration. Center for Biologics Evaluation and Research. Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine. clinical trials. Accessed April 25, 2007.
  9. Mesko TW, Garcia O, Yee LD, et al. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) as a consequence of neck dissection. J Laryngol Otol 1997;111(5);449–453. DOI: 10.1017/s0022215100137612
  10. Talmi YP, Hoffman HT, McCabe BF. Syndrome of inappropriate secretion of arginine vasopressin in patients with cancer of the head and neck. Ann Otol Rhinol Laryngol 1992;101(11):946–949. DOI: 10.1177/000348949210101111
  11. Ferlito A, Rinaldo A, Devaney KO. Syndrome of inappropriate antidiuretic hormone secretion associated with head and neck cancers: review of the literature. Ann Otol Rhinol Laryngol 1997;106(10):878–883. DOI: 10.1177/000348949710601014
  12. Misra UK, Kalita J, Bhoi SK, et al. A study of hyponatremia in tuberculous meningitis. J Neurol Sci 2016;367:152–157. DOI: 10.1016/j.jns.2016.06.004
  13. Iyer AV, Krasnow SH, Dufour DR, et al. Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer. Clin Lung Cancer 2003;5(3):187–189. DOI: 10.3816/CLC.2003.n.033
  14. Zhou L, Chen J, Tao CJ, et al. Research progress of radiation-induced hypothyroidism in head and neck cancer. J Cancer 2021;12(2):451–459. DOI: 10.7150/jca.48587
  15. Carlé A, Pedersen IB, Knudsen N, et al. Gender differences in symptoms of hypothyroidism: a population-based DanThyr study. Clin Endocrinol (Oxf) 2015;83(5):717–725. DOI: 10.1111/cen.12787
  16. Floriani C, Gencer B, Collet TH, et al. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J 2018;39(7):503–507. DOI: 10.1093/eurheartj/ehx050
  17. Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA 2019;322(2):153–160. DOI: 10.1001/jama.2019.9052
  18. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010;304(12):1365–1374. DOI: 10.1001/jama.2010.1361
  19. DeGroot LJ. Radiation and thyroid disease. Baillieres Clin Endocrinol Metab 1988;2(3):777–791. DOI: 10.1016/s0950-351x(88)80065-x
  20. Hancock SL, McDougall IR, Constine LS. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys 1995;31(5):1165–1170. DOI: 10.1016/0360-3016(95)00019-U
  21. Jereczek-Fossa BA, Alterio D, Jassem J, et al. Radiotherapy-induced thyroid disorders. Cancer Treat Rev 2004;30(4):369–384. DOI: 10.1016/j.ctrv.2003.12.003
  22. Koc M, Capoglu I. Thyroid dysfunction in patients treated with radiotherapy for neck. Am J Clin Oncol 2009;32(2):150–153. DOI: 10.1097/COC.0b013e3181845517
  23. Rubin P. Law and order of radiation sensitivity. Absolute versus relative. Front Radiat Ther Oncol 1989:23:7–40. PMID: 2697668.
  24. Emami B. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys 1991;21(1):109–122. DOI: 10.1016/0360-3016(91)90171-y
  25. Goldstein DA. Serum Calcium. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 143.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.